Presented by REX Shares: 2X daily leverage on SK hynix? Here’s how to trade it.

Bank earnings season kicked off this morning, and the market’s verdict is blunt: beating expectations is not enough. Several of Wall Street’s biggest names topped estimates and are getting sold anyway, while a legacy tech giant is cratering after warning its quarter fell short.

The exceptions tell the story. One investment bank delivered a beat too big to ignore, and a chip giant is clawing back Monday’s losses, a reminder that in a priced-for-perfection tape, only the standouts get paid.

The T-REX 2X Long SKHY Daily Target ETF (HYNX) is now trading, seeking 200% of the daily performance of the SK hynix ADR (SKHY) — 2X daily exposure to the memory chips used in servers and data centers, in one ticker.

Visit rexshares.com/hynx for the prospectus and risk disclosures.

Goldman Sachs (GS): +3%

Goldman blew past second-quarter expectations on both earnings and revenue by a wide margin, and on a day when beats elsewhere are getting sold, the sheer size of the beat is proving hard to ignore.

NVIDIA (NVDA): +2%

The AI chipmaker is climbing before the bell. For the market’s most-watched stock, even a modest premarket bounce draws attention, and traders will be watching whether it holds through the open.

IBM (IBM): -22%

The legacy tech giant is in freefall after preliminary second-quarter results came in below what analysts were expecting. Pre-announcing a miss is rare, and the market tends to read it as a sign to sell.

LM Ericsson (ERIC): -10%

The Swedish networking and telecom provider posted revenue that missed expectations. For a company tied so closely to global carrier spending, a top-line shortfall lands hard, and investors are not waiting around for the full picture.

Citigroup (C): -1%

Citigroup delivered its best quarterly revenue in a decade and beat on both lines, and the stock is falling anyway. When a result that strong gets sold, it says more about how much good news was already priced in than about the quarter itself.

Wells Fargo (WFC): -1%

Another beat that is not getting paid. Wells Fargo topped expectations on both earnings and revenue, but shares are slipping anyway, fitting this morning’s pattern of bank beats meeting sellers.

Apple (AAPL): -1%

KeyBanc downgraded the iPhone maker to Underweight from Sector Weight, with a price target implying roughly 21% downside. The firm expects pressure as customers tighten their spending in response to rising prices, a demand worry that strikes directly at Apple’s premium pricing.

The T-REX 2X Long SKHY Daily Target ETF (HYNX) is now trading, seeking 200% of the daily performance of the SK hynix ADR (SKHY) — 2X daily exposure to the memory chips used in servers and data centers, in one ticker.

Visit rexshares.com/hynx for the prospectus and risk disclosures.

Sellas Life Sciences (SLS)

Retail traders have made this small-cap biotech one of the most talked-about tickers on StockTwits, with chatter centered on its Phase 3 REGAL trial in acute myeloid leukemia, now at 78 of the 80 events needed to trigger final analysis. This morning the conversation is fixated on a reported $5.8 million bet on September $30 calls, which traders are reading as someone positioning ahead of the readout.

The stock has surged 537% over the past year. StockTwits sentiment has been running extremely bullish amid heavy message volume, and buyout speculation keeps building around updated executive change-of-control terms. Whether the data delivers or the speculation unwinds, the readout could be the moment that decides which story wins.

✌️That’s it for today.